Location
United States, North America
Cheque size
$500K - $40M
Investment Stage
Pre Seed
Seed
Series A
Series B
Focus Areas
BioTech
About Investor
Tom M. Thomas is an Investor and Principal at Newpath Partners focused on biotechnology companies from pre-seed through Series B. His reported investment range is $500K to $40.0M. Thomas previously worked in healthcare investing and company-building roles tied to life sciences innovation. He supports founders commercializing breakthrough therapeutics and healthcare technologies.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.